Journal of Jilin University(Medicine Edition) ›› 2021, Vol. 47 ›› Issue (2): 360-368.doi: 10.13481/j.1671-587X.20210215
• Research in basic medicine • Previous Articles Next Articles
Guo HUANG1,Youquan WANG1(),Juan CHEN2
Received:
2020-08-15
Online:
2021-03-28
Published:
2021-03-25
Contact:
Youquan WANG
E-mail:gfzq1410@163.com
CLC Number:
Guo HUANG,Youquan WANG,Juan CHEN. Reverse effect of miR-138-5p targeted inhibition of HIF-1α expression on cisplatin resistance of breast cancer MCF-7 cells and its mechanism[J].Journal of Jilin University(Medicine Edition), 2021, 47(2): 360-368.
1 | BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. |
2 | PLEVRITIS S K, MUNOZ D, KURIAN A W, et al. Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012[J]. JAMA, 2018, 319(2):154-164. |
3 | 顾 峰, 周 岩, 韦培培. 乳腺癌患者外周血miRNA-134表达及化疗耐药的机制[J]. 重庆医学, 2018, 47(6):779-782. |
4 | 高 洁, 李晨曦, 赵 辉, 等. miR-19a-3p通过靶向PIK3CB参与调控雌激素受体阳性乳腺癌化疗耐药的相关研究[J]. 生物技术通讯, 2018, 29(5):587-592. |
5 | ZHAO C, LING X, LI X, et al. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1[J]. Breast Cancer, 2019, 26(6):817-825. |
6 | GAO Y, FAN X, LI W, et al. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124[J]. Biochem Biophys Res Commun, 2014, 446(1):179-186. |
7 | 闫东科, 吕 平. 低氧诱导因子及其抑制剂研究进展[J]. 生物技术进展, 2019, 9(4):332-340. |
8 | XU K, ZHAN Y, YUAN Z, et al. Hypoxia induces drug resistance in colorectal cancer through the HIF-1α/miR-338-5p/IL-6 feedback loop [J]. Mol Ther, 2019, 27(10):1810-1824. |
9 | TRÉDAN O, GALMARINI C M, PATEL K, et al. Drug resistance and the solid tumor microenvironment[J]. J Natl Cancer Inst, 2007, 99(19):1441-1454. |
10 | 卢明华, 陶功财, 方亚男, 等. 缺氧导致胃癌化疗耐药的研究进展[J]. 中国肿瘤临床, 2019, 46(13):700-703. |
11 | MÉNDEZ-BLANCO C , FONDEVILA F, GARCÍA-PALOMO A, et al. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors[J]. Exp Mol Med, 2018, 50(10):1-9. |
12 | HAYES J, PERUZZI P P, LAWLER S. MicroRNAs in cancer: biomarkers, functions and therapy[J]. Trends Mol Med, 2014, 20(8):460-469. |
13 | SHIN V Y, Chu K M. MiRNA as potential biomarkers and therapeutic targets for gastric cancer[J]. World J Gastroenterol, 2014, 20(30):10432-10439. |
14 | 余灵芝, 戴丹平, 项秀瑶. miR-20b通过抑制JAK/STAT3信号通路逆转结肠癌细胞5-FU耐药性的研究[J]. 世界华人消化杂志, 2019, 27(9):544-550. |
15 | 何 平, 王 平, 熊隆信. miR-429通过下调PTEN并激活PI3K/AKT信号通路促进胰腺癌PANC-1细胞对卡培他滨耐药[J]. 中国肿瘤生物治疗杂志, 2018, 25(12):1251-1258. |
16 | XIAO F, LI Y, WAN Y, et al. MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B[J]. Cancer Chemother Pharmacol, 2018, 81(5):935-947. |
17 | NING J, JIAO Y, XIE X, et al. miR-138-5p modulates the expression of excision repair cross-complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin[J]. Oncol Rep, 2019, 41(2):1131-1139. |
18 | PAN X, CHEN Y, SHEN Y, et al. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7[J]. Cell Death Dis, 2019, 10(6): 429. |
19 | LIANG Z, FENG Q, XU L, et al. CREPT regulated by miR-138 promotes breast cancer progression[J]. Biochem Biophys Res Commun, 2017, 493(1):263-269. |
20 | LIU D, ZHANG Q, WANG J, et al. Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer[J]. Pharmazie, 2019, 74(2):83-90. |
21 | WANG K, ZHU X, ZHANG K, et al. Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α[J]. J Biochem Mol Toxicol, 2018, 32(3):e22039. |
[1] | Xiulan YE,Ming LI,Zhaojian WANG,Haiyan ZHAO,Jianning MA,Jing LIU,Yi ZHENG,Shunqing LI,Yu ZHANG. Effects of Cornus officinalis polysaccharide on behavior and multidrug resistance gene 1b and major vault protein expressions in hippocampus tissue of refractory epilepsy young rats [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 644-651. |
[2] | Aihua REN,Wan LIU,Dawei WANG. Influence of PD-L1 knockout based on CRISPR/Cas9 technology in gefitinib resistance sensitivity of PC-9/T790M in non-small cell lung cancer [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 292-298. |
[3] | Guang YAO,Yuying LU,Qinghua ZHANG,Haixia ZHU,Yiwei CHEN,Dong SUN,Zhen ZHUANG,Feng ZHANG,Ding LIU,Zhi SONG. Genomic evolution and drug resistance analysis of human-derived Listeria monocytogenes [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 180-186. |
[4] | REN Aihua, WANG Dawei. Effect of CRISPR/Cas9-mediated TKI on sensitivity of non-small cell lung cancer gene targeting gefitinib resistance and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1288-1293. |
[5] | YANG Li, WANG Xuewen, ZHOU Ming, ZHANG Fan. Effect of arsenic trioxide combined with γ-secretase inhibitor MW167 on drug resistance of human hepatocellular carcinoma HepG2/ADM cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 1-7. |
[6] | ZHOU Haoquan, CHU Xinmin, DAI Yuanyuan, DAI Chuanlin, PAN Jiahua. Clinical characteristics and drug resistance analysis of non-fermentative bacteria infection in infants [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 975-979. |
[7] | HUI Shuang, GUO Hongqiang. Chemoresistance of multi-drug resistance malignant glioma cells mediated by DNA-PKcs and its molecular mechanism [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 877-881. |
[8] | JIANG Hui, ZHANG Tongfei, YANG He, XU Zhaonan, BI Ye, SUN Shu, ZHANG Zebing, JIA Jie. Establishment of human tongue squamous cell carcinoma cisplatin resistant cell line CAL-27/DDPand its biological evaluation [J]. Journal of Jilin University Medicine Edition, 2016, 42(03): 506-511. |
[9] | ZHANG Peng, CHE Lihe, GUO Zhimin, LOU Lixin, BAO Wanguo, LI Yuxiang. Analysis on distribution and drug resistance of pathogens in patients with urinary tract infections [J]. Journal of Jilin University Medicine Edition, 2015, 41(03): 593-598. |
[10] | WANG Huai-dong,ZHANG Xiao-tian,ZHANG Chao,GUAN Shi-hui,DONG Jun-xue,MU Jia,WANG Fang,ZHENG Jing-tong. Application of DNA sequencing technology in study on mechanism of resistance of Escherichia coli under different drug pressure [J]. Journal of Jilin University Medicine Edition, 2014, 40(01): 109-112. |
[11] | XUE Hui-rong,WANG Li-ping,GENG Jia-nan,CUI Man-hua. Mechanism of resistance of ovarian cancer cell SKOV3/DDP reversed by HIF-1α gene silencing [J]. Journal of Jilin University Medicine Edition, 2013, 39(6): 1103-1107. |
[12] | LI Ping|ZHANG Jie|LI Ya-rong|WANG Ke|SU Zhen-zhong . Reversal effect of Ku70-targeted siRNA on chemoresistance to cisplatin in human lung adenocarcinoma cells [J]. J4, 2012, 38(2): 240-245. |
[13] | CUI Dian-long|XIE Bai-yi|HU Meng|XIANG Xin|BAO Chuan-en,CHEN Yu-qiang. Inhibitory effect of tetraiodothyroacetic acid on proliferation of drug- resistant human gastric cancer cell line in vivo and in vitro [J]. J4, 2012, 38(2): 281-285. |
[14] | SHEN Yu|WANG Chun-mei,HUANG Ying|HE Xiao-fang. Relationship between changes of drug resistance of Acinetobacter baumannii strains and preferences of clinical antibiotics adoption [J]. J4, 2011, 37(5): 885-889. |
[15] | LUO Dan,XIANG Yan-gen,PAN Jian-hua,PENG Xue-feng,DENG Wei-zhi,SHI Guo-min. Detection of |three-drug resistance related genes of mycobacterium tuberculosis by |membrance reverse dot blot hybridization [J]. J4, 2011, 37(4): 759-762. |
|